Jan, 29th 2021 – Germany’s vaccine committee has said AstraZeneca’s Covid jab should only be given to people aged under 65. The committee has cited insufficient data over its efficacy for older people.
The European Medicines Agency is to decide today whether to approve the vaccine for use across the EU. The move comes as European countries face vaccine shortages and criticism over the pace of vaccination.
UK-based AstraZeneca, says production issues at its Europe-based plants, mean it will be unable to deliver the promised number of doses to the bloc. However, the European Union says the firm must honor its commitments and deliver the jabs by diverting stock from the UK.
The UK has been using the AstraZeneca vaccine in its mass immunisation programme for weeks now. According to public health officials, the vaccine is safe and provides high levels of protection.
According to Dr. Mary Ramsay, Head of Immunizations at Public Health England, both the vaccines, AstraZeneca and Pfizer-BioNTech, provide high levels of protection against the virus.
She said, “There were too few cases in older people in the AstraZeneca trials to observe precise levels of protection in this group, but data on immune responses were very reassuring.”
Boris Johnson, UK Prime Minister says that he is not worried by the German recommendation. He says that the British Health Authorities have made clear that the AstraZeneca vaccine is effective across all age groups.